AKT1 and malignant peripheral nerve sheath tumor: It is noteworthy that, AKT and PI3K pathways were recently found to be highly activated in MPNST cell lines so that AKT activation blockade, either by inhibition of the PI3K upstream or directly through AKT inhibitors, may potentially be pursued as a systemic anti-MPNST approach [81]–[82].